Research progress in clinical application of lymphoplasmapheresis in immune-related diseases
Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 8
Abstract
Lymphoplasmapheresis(LPE) is a combination of plasma exchange and lymphocyte separation technology. It can not only remove autoimmune antibodies, but also remove the immune active cells producing these antibodies. At the same time, it can inhibit cellular and humoral immune responses, and improve the efficiency and reliability of treatment. This technology is safe, reliable, and easy to operate. In recent years, it has been widely used in the treatment of various autoimmune diseases and the suppression of immune rejection after organ transplantation, especially in the treatment of critically ill patients. This paper summarizes the clinical application status of LPE in immune-related diseases at home and abroad, analyzes the problems existing in the clinical promotion of LPE, and makes a prospect of its application value.
Authors and Affiliations
Shipeng KE, Xu LI, Ling YU, Ting HUANG, Huixia ZHANG, Fen HU, Shubiao ZOU, Meiying RAO, Simei CHEN
Keywords
Related Articles
- EP ID EP738333
- DOI 10.13303/j.cjbt.issn.1004-549x.2022.08.026
- Views 60
- Downloads 0
Inhibitory effect of Salidroside on the interaction between human platelets and breast cancer MDA-MB-468 cells
Objective To study the effect of Salidroside(Sal) on platelet activation and aggregation and the interaction between human platelets and MDA-MB-468 cells of breast cancer. Methods Human platelets were collected, platelet...
Analysis on testing ability of blood testing laboratories in domestic blood establishments across China
Objective To analyze testing ability of blood testing laboratories in domestic blood establishments, and to comprehensively understand the resource allocation, workload and unqualified blood samples. Methods All blood te...
False positive reaction of COVID-19 antibody ELISA screening: internal logic of various methods
Objective To analyze the results of different methods for reactive samples screened by the enzyme linked immunosorbent assay (ELISA) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in blood donors. M...
The applicability of Beckman PK7300 fully automatic blood group instrument for TPPA detection
Objective To investigate the applicability of Beckman PK7300 for TPPA testing on anti-TP reactive specimens from blood donors. Methods 1) The TPPA test using Beckman PK7300 (abbreviated as instrument method) had been est...
Study on the production efficiency of platelet components in 24 prefecture-level blood stations in China
Objective To learn the production efficient of platelet components among prefecture-level blood stations in China, to provide supporting data for those blood stations to optimize the production mode of platelet component...